Clinical Trials Directory

Trials / Completed

CompletedNCT01322035

Erythrocyte and Adipocyte G6PD Activity Levels in Obesity

Erythrocyte and Adipocyte G6PD Activity Levels Correlate With Differing Degrees of Dyslipidemia, Insulin Resistance and Obesity

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
University of South Alabama · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study compares the improvement of weight, fasting lipid profile (triglycerides, cholesterol, HDL, and LDL) and diabetes after gastric bypass surgery with an improvement in levels of an enzyme called glucose-6-phosphate dehydrogenase (G6PD).

Detailed description

Same as brief summary

Conditions

Timeline

Start date
2009-12-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2011-03-24
Last updated
2024-05-16
Results posted
2024-05-16

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01322035. Inclusion in this directory is not an endorsement.

Erythrocyte and Adipocyte G6PD Activity Levels in Obesity (NCT01322035) · Clinical Trials Directory